On successful closure of USFDA inspection
Natco Pharma has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the pre-approval inspection conducted at its drug formulations facility in Kothur village, Telangana, India, during the period from 2 March to 6 March, 2020.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content